The well-known unique healing properties of bee venom peptides in combination with New Zealand Manuka honey make the product beneficial for many health conditions to maintains well -being .
Oral intake of Manuka VENZ™ is infinitely more pleasant than old-fashioned Bee sting therapy to maintain good health. This product provides an alternative method of achieving the possible health benefits of bee sting therapy without enduring the pain from bee stings.
Maximum penetration of bee venom into bloodstream when taking Manuka VENZ™ is carried out through the larynx and mouth mucous membranes. This affects every part of the body starting with cell membranes and finishing with painful body parts. It provides the body’s central system with a regulating influence over internal corticosteroid hormonal secretion.
For manufacturing of Manuka VENZ™ Apihealth use own-patented technology (Patent #333790), which allow to produce safe product with excellent beneficial properties.
What is so special about Bee Venom Value
Bee venom is a unique multi-component complex, which contains about 30 biologically active compounds, some of which are practically impossible to get synthesized by chemical methods. The main components are peptides: melittin, apamin, peptide 401, adolapin, and protease inhibitors.
Bee venom has multiple effects on the body: help keep the blood circulation in normal, support physical strength and well being, support to joint mobility, has anti-oxidant effects, support to the immune system.
Bee venom might modify the immune system functions in the body and contribute to the increased production of cortisol. The healing potency of BV in the treatment of arthritis and rheumatism is initiated after stimulating the production of cortisol in the adrenal glands.
In animal studies conducted last year, doctors in South Korea found that melittin, the principal peptide in bee venom, blocks the expression of inflammatory genes that can cause painful tissue swelling in rheumatoid arthritis patients.
Next, researchers tested the anti-inflammatory effects of melittin on human synovial cells of arthritis patients. Synovial cells are those that line the joints, and which are vulnerable to inflammation among arthritis sufferers.
They found the melittin blocked the expression of the genes that cause the inflammation and pain suffered by arthritis patients. The melittin worked in a similar way to a class of drugs called cox-2 inhibitors, which are now used to treat rheumatoid arthritis and reduce inflammation, the scientists wrote.